Lipid Profile in Metabolic Syndrome Associated with Diabetes, Hypertension, Chronic Kidney Disease and Apparent Health

Background: There is dyslipidaemia in metabolic syndrome (MetS). Lipid profiles MetS associated with different health conditions may not be obvious. This study investigated lipid type 2 diabetes (DM-MetS), hypertension (HBP-MetS), chronic kidney disease (CKD-MetS) and apparent (AH-MetS). Methods: 540 patients were recruited for this study; 183 T2D, 136 HBP, 84 CKD 137 AH subjects. They outpatients workers the University of Nigeria Teaching Hospital Enugu. Nigeria. FPG, TC, HDL-C, TG as well anthropometric measurements determined using standard methods. Data analyses done GraphPad Prism version statistical programme. was diagnosed NCEP-ATP 111 criteria Results: Study showed 135 DM, 64 31 52 subjects had MetS, (prevalence rates: 36.9 %, 14.7 18.4 37.9 % respectively). Only 38% hypertriglyceridaemia while 66% MetS. Corresponding figures low HDLC 40, 77%. CKD-MetS higher mean value TC than others; (2.65 ± 0.16 mmol/l; F = 11.4; P =0.0001; 6.07±0.02mmol/l; p 0.001). Variations observed across groups, (p =0.0001). HDL-C highest AH-MetS, (1.51 ±0.07 mmol/l) differed DM-MetS, (1.23 0.04mmol/l, p=0.01) only. Following pattern LDLC lowest among (2.75 0.06 CKD-MetS, (3.65 0.28 mmol/l, =0.001) variations (F 6.35; p= 0.0004). Conclusion: Dyslipidemia profile varied disorders. Presence a strong factor development disorders population.